EN: Navigation mit Access Keys
- [Alt + 0] - Startseite
- [Alt + 1] - Navigation
- [Alt + 2] - Inhalt
- [Alt + 3] - Contact
- [Alt + 4] - Sitemap
- [Alt + 5] - Search
Click links above to access full Prescribing Information for each product.
Indications for Octagam 5%
Octagam 5% is indicated for the treatment of primary humoral immunodeficiency (PI), such as congenital agammablobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Indications for Octagam 10%
Octagam 10% is indicated for the treatment of chronic immune thrombocytopenic purpura (ITP) in adults.
Important Risk Information for Octagam 5% and Octagam 10% Liquid
WARNING: THROMBOSIS, RENAL DYSFUNCTION and ACUTE RENAL FAILURE
Please see full prescribing information for complete boxed warning.
- Thrombosis may occur with immune globulin intravenous (IGIV) products, including Octagam 5% and Octagam 10%. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors.
- Renal dysfunction, acute renal failure, osmotic nephropathy, and death may occur with the administration of Immune Globulin Intravenous (Human) (IGIV) products in predisposed patients. Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. Octagam 5% and Octagam 10% do not contain sucrose.
- For patients at risk of thrombosis, renal dysfunction or renal failure, administer Octagam 5% and Octagam 10% at the minimum infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.
Octapharma USA, Inc.
121 River Street, Suite 1201
Hoboken, New Jersey 07030
USA
Tel. +1 201-604-1130
Fax +1 201-604-1131
Reimbursement:
usreimbursement@octapharma.com
Tel. 800-554-4440
Fax 800-554-6744
Medical Affairs:
usmedicalaffairs@octapharma.com
Tel. 888-429-4535
Drug Safety Officer:
Office 201-604-1137
Cell 201-772-4546
Fax 201-604-1141
Customer Service:
uscustomerservice@octapharma.com
Tel. 866-766-4860
Authorized Product Distributors:
- FFF Enterprises, Inc.
- ASD Specialty Healthcare, Inc.
- Cardinal Health
- McKesson Plasma and Biologics LLC
- McKesson Specialty Health
- BDI Pharma, Inc.
- Health Coalition, Inc.
- Prodigy Health Supplier Corporation
- Smith Medical Partners LLC
- New York Blood Center
- United Blood Services (BioCare)
- National Hospital Specialties
- The Alliance Pharmacy
For more information on Octapharma International, please follow this link. Please note that the Octapharma International web pages may contain information on products not approved for use in the US and/or product uses not approved in the US.